Covid-19, Pulmonary Embolism
Conditions
Brief summary
The charts of patients who developed pulmonary embolism in the course of COVID-19 will be evaluated, retrospectively. Clinical features and laboratory data will be analyzed.
Detailed description
Patients with COVID-19 infection will be evaluated retrospectively. Demographic data, clinical and laboratory findings will be recorded. Findings of patients with pulmonary embolism and withour pulmonary embolism will be compared.
Interventions
OTHERintensive care unit admission ratio
intensive care unit admission ratio
Sponsors
Uşak University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Inclusion criteria
\- All patients with positive RT-PCR for COVID-19
Exclusion criteria
\- All patients with negative RT-PCR for COVID-19
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pulmonary embolism | 1 year | development of pulmonary embolism |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intensive care unit | 1 year | need for admission to intensive care unit |
| mortality | 1 year | mortality rate due to pulmonary embolism |
Countries
Turkey (Türkiye)
Contacts
Primary ContactCevdet Duran, M.D.
Outcome results
None listed